UNSPSC 51263107: Befunolol

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51263107

Definition

This classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula C16H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 418546MT3A, chemically known as ketone, 7-(2-hydroxy-3-(isopropylamino)propoxy)-2-benzofuranyl methyl but generally known as befunolol, which bears US NIH Compound Identifier 2309. Befunolol most often comes in base and hydrochloride forms.

Read the full definition

European Medicines Agency schedules Befunolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05682MIG. The term BEFUNOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules befunolol in its Anatomical Therapeutic Chemical (ATC) Classification. BEFUNOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule befunolol under HS 29329985 and SITC 51569.

As of Q4 2014, BEFUNOLOL remains the US FDA Preferred Term for this commodity. Befunolol bears US NLM identifiers UMLS ID C0053071 and NCI Concept Code C73021. SMILES: O(CC(O)CNC(C)C)C1C2OC(CC2CCC1)C(=O)C.

About UNSPSC 51263107

UNSPSC 51263107 Befunolol is a Commodity code that does not align with the state and local procurement activity tagged under it. The single recent opportunity in the database—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and drug deactivation systems for community health and emergency response use, not befunolol, a beta-blocker pharmaceutical. The mismatch between the code's nominal scope and actual procurement suggests either a tagging error at the source or that befunolol procurement under this code does not materialize in the available state and local contract records.

Seminole County's solicitation, due July 26, 2023, represents a straightforward commodity purchase: 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building. The county requires electronic bid submission, unit pricing, E-Verify compliance, workers' compensation and general liability insurance, and a three-month probationary termination clause. The contract runs two years with a one-year renewal option and is potentially FEMA-funded, introducing federal compliance requirements. No recent state and local opportunities for befunolol itself appear in the database, and the geographic scope and issuing-body mix cannot be characterized from a single mistagged naloxone opportunity. Firms evaluating this code should confirm whether state and local agencies are actually procuring befunolol or related cardiovascular pharmaceuticals under different UNSPSC codes, as the current data shows little relevant activity.

Quick answers

What is UNSPSC 51263107?

UNSPSC 51263107 is Befunolol, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51263107?

UNSPSC 51263107 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51263107

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code